The purpose of investigation is to study role of biomarkers in progression of chronic cerebral ischemia (CCI). Material and methods: It was examined 355 patients with CCI (main group). Among of them there were 230 women and 125 men. Average age was 55.30 ± 7.91 years. Control group consisted of 50 clinically healthy people (28 women and 22 men) without any signs of cerebrovascular diseases (CVD). Average of age 52.30 ± 8.51 years. Clinical-neuropsychological, laboratory and instrumental methods of examination were used in the given work. For the determination of CCI progression factors it was applied a logistic regression analysis. Results. Presence of leukoaraiosis areas, postischemic cysts, combined focal lesion of white substance and dilation of subarachnoid spaces or/and ventricular system of brain, S100 protein, presence of atherosclerotic plaques in common carotids, age, bodymass index, type 2 diabetes mellitus, dyslipidemia, cholesterol of low density lipoproteins, systolic blood pressure, antibodies to NR2 peptide, male sex and homocysteine of blood are independent predictors of DE progression. Corrected ROC-analysis showed that using as a standard prognostic model (Model 1) a combined index of white substance focal lesion, dilation of subarachnoid spaces or/and ventricular system of brain a magnitude AUC = 0,612 that indicates about sufficiently high system reliability. At that, a combined usage of three biomarkers (homocysteine + S100 protein + antibodies to NR2) significantly increases a prognostic value of Model 1 (p=0,002). Conclusions: Combined usage of studied biomarkers such as homocysteine, S100B protein and antibodies to NR2-peptide in blood plasma together with dete-
Introduction
Cerebrovascular diseases (CVD) take a leading position among main reasons of mortality and disability of population [7] . Despite the investigations in cerebral stroke treatment the most optimal approach in prevention of this disease is an early recognition of chronic cerebral ischemia (CCI) when pathologic changes in a cerebral tissue are not reversible and preventive measures are the most efficient. [8] . Current investigations allowed to broaden a conception concerning metabolic aspects of chronic ischemia when a development of a number of biochemical and immunologic processes take place and lead to a neuronal death. Arterial hypertension (AH), hypercholesterolemia, type 2 diabetes diabetes (T2DM), cardiac rate abnormalities, overweight, smoking, hypodynamia are traditional risk factors of CVD. But last time in scientific literature it was discussed a number of new risk factors of atherosclerosis. Among these factors is hyperhomocysteinemia (HHC) that is even considered to be an alternative to hypercholesterolemia [1] . The investigators assume that homocysteine (HC) damages endothelium of blood vessels and facilitate cholesterol precipitation and platelet adhesion that leads to accelerated atherosclerosis progression, thrombus formation and development of associated diseases such as venous thrombosis, ischemic heart-disease and CCI [11] . HC metabolite such as homocysteine acid has excitotoxic properties and stimulates NMDA-receptors that causes epactal calcium ion flux into cells and formation of a huge number of free radicals. HC influence on brain vessels leads to cerebral ischemia, hypoxia and neurons damage. In particular, as a result of the increase of HC level in blood serum an oxidative stress arises causing vascular walls damage, proliferation of vascular elements and development of prothrombotic state. In the process of oxidative stress development it is significant to take into account an enhancement of peroxidation of low density lipids and the increase of platelet aggregation. All that causes to prothrombinogen development of clinically evident or asymptomatic cerebral strokes [3] .
Clinical investigations showed that protein S100В concentration factor in cerebrospinal fluid and in blood plasma can give useful information for clinical management of patients with cerebral tissue affection. The increase of S100В protein concentration in cerebrospinal fluid and in blood plasma is not only a marker of brain substance affection and but it shows the level of this affection [6] . It is known, that glutamatergic neuron lesion leads to accumulation of antibodies with glutamate receptors of NMDA-type, which level is a criterion of cerebral tissue ischemization [4] .
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Even in case of high actuality of the problem concerning prophylaxis of CVD complications, pathogenetic aspects of CCI are not sufficiently studied for today. Also, data concerning the peculiarities of neuro-immune reactions among patients with different stages of discirculatory encephalopathy (DE) remain limited. Thus, an early search of biomarkers of CVD progression is relevant.
The purpose of investigation is to study biomarkers role in progression of chronic cerebral ischemia.
Materials and methods
It was examined 355 patients with CCI (main group), among of them 230 women and 125 men. Etiological factors of the disease among a predominant majority (98%) of patients were combination of cerebral atherosclerosis and arterial hypertension. The diagnosis was formulated due to the classification of vascular involvements of brain ICD-Х and was confirmed by data of instrumental and laboratory investigations (computed tomography (CT) / magnetic resonance imaging (MRI) of brain, duplex scanning of brachiocephalic vessels, fundus examination, lipid profile, coagulation tests With the purpose of carrying out laboratory investigations it was drawn blood from ulnar vein from 8.00 till 9.00 a.m. on empty stomach after 12-hours fasting. Biochemical investigation was carried out using automatic biochemical analyzer Prestige-24i (Japan) with the determination of common cholesterol level and lipid fractions of cholesterol -low-density lipoproteins (LDL), cholesterolhigh-density lipoproteins (HDL), triglycerides. Blood serum was separated using centrifugation method and it was immediately frozen at a temperature 70 0 С until the moment of analysis performance. HC contents were determined by means of immune-enzyme method using diagnostic kits "Axis Homocysteine EIA" (United Kingdom). Laboratory investigation for the determination of antibodies to NMDA-receptors was carried out using diagnostic kit for determination of NR2-antibodies in blood of patients. Determination of biomarker in a serum of investigated blood was realized by means of immune-enzyme analysis using special test-system GoldDotNR2 Antibodytest -antibodies to NR2 of NDMAreceptors subunit (Biotech, Inc., USA). Protein S100В concentration was defined with the help of immune-enzyme analysis method using standard sets of reagents: CanAg S100 EIA (FUJIREBIO Diagnostic, Inc, Sweden).
The investigation of brachiocephalic vessels state was performed using duplex-triplex scanner LOGIQC-5 Premium (USA). Structural changes of cerebral tissue among patients with DE were studying using CT methods and were carried out using spiral computer tomographic scanner «SOMATOM Spirit» of Siemens company production and MRI using the device «Hitachi Airis Mate» of Japan producer -Hitachi Medical Corporation. During the analysis there were taken into consideration presence and degree of dilation of the subarachnoid spaces and lateral ventricles, intensity and localization of leukoaraiosis and presence of postishemic focuses, their localization and dimensions.
Statistics
Statistical methods. The results of the investigation are treated using a statistical program «STATISTICA® forWindows 6.0» (StatSoftInc., USA, № AXXR712D833214FAN5) and also using «MicrosoftExcel 2010». To test a hypothesis of normality of distribution was applied Shapiro-Wilk criterion. Data of descriptive statistics are represented as arithmetical mean and standard deviation -М±SD or median and interquartile range -Me (Q1-Q3) depending on factor of distribution. A correlation analysis was performed using Spearman criterion. Potential factors of progression were primarily determined using a single-factor analysis of variance (ANOVA) and then all identified factors with the level р<0,1 were studied optionally in multivariate analysis. C-statistics was used in order to compare actual prognostic models with standard ABC model. Odds ratio (OR) and 95% confidence interval (CI) were calculated for all independent predictors of CCI progression. The differences considered to be significant on condition that p<0,05.
Results and discussions
Among the examined patients with CCI in a predominant majority (64,8 %) were women (Table 1) . This is accorded with data of foreign and native researches in which a correspondence of CVD development among women and men is reflected as 2:1 [2, 9] . Among the predictors of CVD the most significant are AH (98,0 %), dyslipidemia (74,6 %) and psycho-emotional overstrain (78,0 %). Contents of biomarkers in blood plasma of patients with CCI are represented in Table 2 . HC level among the examined patients with CCI was 11.89 (7.73 -14.94) mcmol/L and was significantly (p<0.01) higher in comparison with the group of healthy people which HC level was 8.22 (7.12 -11.39) µmol/L. Among the patients with CCI 37.2% of them had HC level less than 10 µmol/L, 38.6% -10-15 µmol/L and 24.2% of patients exhibited HHC. Even at early stages of DE generalized reaction on structural components of cerebral tissue develops by the way of the increase of brain-specific protein S100В contents. These results indicate that among the patients with CCI, microglia suffers most of all, which has trophic and regulatory functions. These functions enable neurons to survive when ischemia occurs [8] . In the performed investigation it was observed significantly (р<0.0001) increased S100В protein level among the patients with CCI -84. 96 It is known that CCI leads to the changes of white substance density with the formation of leukoaraiosis focuses. Diffuse changes of white substance cause disconnection of cortical and subcortical cerebral structures that stipulates appearance emotionally-affective, cognitive and others neurological disorders in a clinical presentation of DE. Besides, ischemic changes of white substance lead to secondary cerebral atrophy [5] .Acute cerebral circulation impairments play an important role in the development and progression of DE with the following formation of postischemic cysts [10] .
During a comparison of the results of neurovisualization and immunoenzyme examinations it was detected a significant (р<0.05) increase of HC level among the patients with leukoaraiosis focuses up to 13.11 (10.28 -14.44) mcmol/L and among the patients with combined focal lesion of white substance and dilation of subarachnoid spaces or/and ventricular system of brain up to 12.2 (8.32 -18.88) µmol/L in comparison with the patients without neurovisualization changes, which HC level was 9.52 (7.49 -12. 0) µmol/L.
It was established a significant (р<0.01) increase of S100В protein level among the patients with leukoaraiosis focuses up to 92.98 (84.96 -103.01) ng/L and among the patients with combined focal lesion of white substance and dilation of subarachnoid spaces and/or ventricular system of brain up to 86.96 (80.95 -102.65) ng/L in comparison with the patients without neurovisualization changes which S100В protein level was 79.08 (68.21 -88.97) ng/L. It was detected a significant (р<0.05) increase of antibodies to NR2-peptide among the patients with combined focal lesion of white substance and dilation of subarachnoid spaces and/or ventricular system of brain up to 3.98 (2.89 -7.83) ng/ml in comparison with the patients having just leukoaraiosis focuses and an enlargement of fluid spaces.
Univariate regression analysis showed ( Table 3 ) that among factors having influence on DE progression the most significant are such as presence of leukoaraiosis areas, postischemic cysts, S100 protein, presence of atherosclerotic plaques in carotid arteries, age, bodymass index, T2DM, dyslipidemia, cholesterol LDL, systolic blood pressure, antibodies to NR2, male sex and homocysteine of blood. During multivariate analysis conduction was found out that indicated above factors such as presence of leukoaraiosis areas, postischemic cysts, S100 protein, presence of atherosclerotic plaques in carotid arteries, age, bodymass index, T2DM, dyslipidemia, cholesterol LDL, systolic blood pressure, antibodies to NR2, male sex and homocysteine of blood preserved their significance as independent predictors of DE progression. At that, among indicated above factors the most strong influence was established for combined index of white substance focal lesion, dilation of subarachnoid spaces or/and ventricular system of brain (OR=1.12), T2DM (OR=1.13), post-ischemic cysts (OR=1.10), antibodies to NR2 (OR=1.09) and S100 protein (OR=1.08) ( Table 4 ). Obtained factors of CCI progression during multivariant regression were used for diagnostic modeling. ROC-analysis adjusted by T2DM (Table 5) showed that using as a standard prognostic model (Model 1) a combined index of white substance focal lesion, dilation of subarachnoid spaces or/and ventricular system of brain a magnitude AUC = 0.612 that indicates about sufficiently high system reliability. Additional usage of factors such as male sex, age, dyslipidemia, presence of atherosclerotic plaques doesn't increase a prognostic value of a standard model. On the contrary, sequential introduction of homocysteine, S100 protein and antibodies to NR2 increases a reliability of Model 1. At that, a combined usage of three biomarkers (homocysteine + S100 protein + antibodies to NR2) significantly increases a prognostic value of Model 1 (p=0,002). 
Conclusions
Thus, the performed investigation showed the increase of studied biomarkers level (homocysteine, S100B protein and antibodies to NR2 peptide) in blood plasma of patients with CCI on different stages of DE in comparison with people without any signs of CVD. Combined usage of studied biomarkers and detection of traditional risk factors of CVD significantly increase a factor of an early diagnostics and a prognostic significance of CCI progression.
